See also this year's filing and all EDGAR filings for this company.
PDF Report 0001664710_2023_Keros_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001664710, Keros Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 285,767,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,021,000 |
| 3 | remainder_Assets | 18,993,000 |
| 4 | LiabilitiesCurrent | 16,547,000 |
| 5 | LiabilitiesNoncurrent | 12,811,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,525,000 |
| 9 | ResearchAndDevelopmentExpense | 87,265,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 10,111,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 306,781,000 |
| 1 | Liabilities | 29,358,000 |
| 2 | Expenses | 114,790,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 277,423,000 |
| 5 | NetIncome | -104,679,000 |
| 6 | ComprehensiveNetIncome | -104,679,000 |
| 7 | BaseVar | 230,520,000 |
| 8 | EconomicCapitalRatio | 2.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
